Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

B of A Securities Downgrades Singular Genomics Sys to Underperform, Announces $3 Price Target

B of A Securities analyst Michael Ryskin downgrades Singular Genomics Sys (NASDAQ:OMIC) from Buy to Underperform and announces $3 price target.
byBenzinga Newsdesk
August 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

B of A Securities analyst Michael Ryskin downgrades Singular Genomics Sys (NASDAQ:OMIC) from Buy to Underperform and announces $3 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Google Parent Alphabet Eyes HubSpot Acquisition: Bloomberg

By Shivani Kumaresan
May 9, 9:27 AM
Alphabet Inc (NASDAQ:GOOGL) eyes HubSpot Inc. (NYSE: HUBS) in a strategic move poised to reshape the CRM sector. With HubSpot's soaring market capitalization and Alphabet's vision to bolster its CRM foothold, the potential acquisition signals a significant shift in the tech landscape. Amidst the surge in HubSpot's shares, Alphabet's interest underscores its commitment to diversify and compete against CRM giants like Microsoft Corp (NASDAQ:MSFT) and Salesforce Inc (NYSE:CRM).

CRM